journal article·2002-02Open access

On the binding of complement to solid artificial surfaces in vitro

Jonas Wetterö, Agneta Askendal, Torbjörn Bengtsson, Pentti Tengvall

Biomaterials· Volume 23· Issue 4

Abstract

Since the realization of a complement activation capacity by artificial surfaces upon contact with blood, a common belief has evolved that charged nucleophilic surface groups such as amine (-NH2) and hydroxyl (-OH) react with and eventually bind to the internal thioester in complement factor 3 (C3). A covalent amide or ester linkage is thereby supposed to form between C3b and the surface itself. In this report, we present complement surface binding data by null-ellipsometry for two nucleophilic surfaces (-NH2 and -OH), for surfaces with immunoglobulin G (IgG) covalently bound, and for IgG spontaneously pre-adsorbed to hydrophobic silicon. The results reveal that the plasma proteins that were deposited during complement activation became eluted by sodium dodecyl sulfate. Hence the direct covalent binding between C3 and solid nucleophilic surfaces seems to be only of moderate importance, at least during shorter serum incubations. This strongly suggests that the prevalent covalent linkage model between solid artificial surfaces and C3b is not accurate. Instead we suggest a more pronounced role for C3 associations to other adsorbed proteins and or electrostatic and hydrophobic protein-surface interactions.
Source: europepmc · Quality: candidate unverified · Source record ↗

Research context

OpenAlex topics: Polymer Surface Interaction Studies · Molecular Junctions and Nanostructures · Advanced biosensing and bioanalysis techniques

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (53)

Show source-provided references
1. Biology of the complement system
2. Factors of the classical pathway
3. Alternative pathway
4. Serum lectin with known structure activates complement through the classical pathway10.1016/S0021-9258(18)47587-4 ↗
5. Lectin Pathway of non-self recognition
6. Complement activation in extracorporeal circuits10.1111/j.1749-6632.1987.tb33051.x ↗
7. Activation of the complement system at the interface between blood and artificial surfaces10.1016/0142-9612(88)90066-X ↗
8. Activation of the alternative pathway of complement by cellulosic hemodialysis membranes10.1038/ki.1989.188 ↗
9. Rapid activation of the complement system by cuprophane depends on complement component C410.1111/j.1523-1755.1998.00836.x ↗
10. Study of complement activation on well-defined surfaces using surface plasmon resonance10.1016/S0927-7765(99)00154-X ↗
11. Complement activation during hemodialysis10.1111/j.1525-1594.1984.tb04291.x ↗
12. A flow cytometric immunoassay to quantify adsorption of complement activation products (iC3b, C3d, SC5b-9) on artificial surfaces10.1002/(SICI)1097-4636(19971215)37:4<474::AID-JBM5>3.0.CO;2-I ↗
13. Interaction between the third complement protein and cell surface macromolecules10.1073/pnas.74.7.2701 ↗
14. Evidence for an ester linkage between the labile binding site of C3b and receptive surfaces10.4049/jimmunol.123.3.1388 ↗
15. The internal thioester and the covalent binding properties of the complement proteins C3 and C410.1002/pro.5560060201 ↗
16. An assessment of the extent of antigenic analogy between physiologically bound C3 and C3 denatured by sodium dodecyl sulphate10.1111/j.1365-3083.1985.tb01933.x ↗
17. SDS denaturation of complement factor C3 as a model for allosteric modifications occurring during C3b binding10.1016/0165-2478(86)90118-5 ↗
18. Distinctive expression of neoantigenic C3(D) epitopes on bound C3 following activation and binding to different target surfaces in normal and pathological human sera10.1016/0161-5890(89)90127-2 ↗
19. Hydrolysis of the covalent bond of C3b-/C3-small-molecule complexes under physiological conditions10.1111/j.1749-6632.1983.tb18119.x ↗
20. Natural release of covalently bound C3b from cell surfaces and the study of this phenomenon in the fluid-phase system10.4049/jimmunol.132.3.1435 ↗
21. The esterase-like activity of covalently bound human third complement protein10.1016/0161-5890(88)90118-6 ↗
22. The covalent-binding reaction of complement component C310.1042/bj1930115 ↗
23. Kern W, Puotinen DA. Cleaning solutions based on hydrogen peroxide for use in silicon semiconductor technology. RCA Rev 1970;June:187–206.
24. Peters DA, Deckert CA. Removal of photoresist film residues from wafer surfaces. J Electrochem Soc 1979;May:883–6.10.1149/1.2129162 ↗
25. Hermansson GT, Mallia AK, Smith PK. Immobilized affinity ligand techniques. San Diego, CA: Academic Press Inc., 1992. p. 51–98.
26. Preparation of immobilized proteins covalently coupled through silane coupling agents to inorganic supports10.1007/BF02916421 ↗
27. Complement activation by 3-mercapto-1,2-propanediol immobilized on gold surfaces10.1016/0142-9612(96)84675-8 ↗
28. Complement activation on thiol-modified gold surfaces10.1002/(SICI)1097-4636(199604)30:4<535::AID-JBM12>3.0.CO;2-G ↗
29. Complement activation on solid surfaces as determined by C3 deposition and hemolytic consumption10.1002/jbm.820280703 ↗
30. Complement activation by IgG immobilized on methylated silicon10.1002/(SICI)1097-4636(199607)31:3<305::AID-JBM3>3.0.CO;2-Q ↗
31. Surface-related triggering of the neutrophil respiratory burst. Characterization of the response induced by IgG adsorbed to hydrophilic and hydrophobic glass surfaces10.1046/j.1365-2249.1997.4311329.x ↗
32. Complement activation on immunoglobulin G-coated hydrophobic surfaces enhances the release of oxygen radicals from neutrophils through an actin-dependent mechanism10.1002/1097-4636(20000915)51:4<742::AID-JBM24>3.0.CO;2-D ↗
33. McCrackin FL. (1969) in NBS Technical Note 479, Washington DC.
34. Ellipsometry as a tool to study the adsorption of synthetic and biopolymers at the air–water interface10.1002/bip.1978.360170711 ↗
35. Blood protein interactions with titanium surfaces10.1163/156856297X00560 ↗
36. Temporal studies on the deposition of complement on human colostrum IgA and serum IgG immobilized on methylated silicon10.1002/(SICI)1097-4636(199704)35:1<81::AID-JBM8>3.0.CO;2-I ↗
37. A wettability gradient method for studies of macromolecular interactions at the liquid/solid interface10.1016/0021-9797(87)90260-8 ↗
38. Complement activation and inflammation triggered by model biomaterial surfaces10.1002/(SICI)1097-4636(199808)41:2<333::AID-JBM19>3.0.CO;2-L ↗
39. Benesch J, Svedhem S, Svensson SCT, Valiokas R, Liedberg B, Tengvall P. Protein adsorption on oligo(Ethylene Glycol) self assembled monolayers: experiments with fibrinogen, heparinised plasma and serum. J Biomater Sci Polym Ed 2001; in press.10.1163/156856201316883421 ↗
40. Components of the alternative pathway
41. CR3 (Mac-1, alpha M beta 2, CD11b/CD18) and Fc gamma RIII cooperate in generation of a neutrophil respiratory burst10.1083/jcb.125.6.1407 ↗
42. C1q triggers neutrophil superoxide production by a unique CD18-dependent mechanism10.1002/jlb.58.2.168 ↗
43. Identification of proteins absorbed to hemodialyser membranes from heparinized plasma10.1163/156856293X00573 ↗
44. Analysis of proteins eluted from hemodialysis membranes10.1163/156856291X00160 ↗
45. Analysis of the complement C3 fragments associated with hemodialysis membranes10.1038/ki.1989.26 ↗
46. Biomedical polymers differ in their capacity to activate complement10.1159/000463181 ↗
47. The opsonic fragment of the third component of human complement (C3)10.1084/jem.141.6.1329 ↗
48. C3 fragmentation in human serum
49. The binding of complement component C3 to antibody-antigen aggregates after activation of the alternative pathway in human serum10.1042/bj1950471 ↗
50. Covalent attachment of human complement C3 to IgG. Identification of the amino acid residue involved in ester linkage formation10.1016/S0021-9258(19)62004-1 ↗
51. Glycosylation of IgA is required for optimal activation of the alternative complement pathway by immune complexes
52. Analysis of recognition in the alternative pathway of complement. Effect of polysaccharide size10.4049/jimmunol.142.8.2766 ↗
53. Analysis of the mechanism of recognition in the complement alternative pathway using C3b-bound low molecular weight polysaccharides10.4049/jimmunol.142.8.2759 ↗